to develop, manufacture, and commercialize  Molecular Formulas available through lipid nano particles in the treatment of Age &  Neuropsychiatric Diseases including,  Anxiety, ADHD, Bipolar, Insomnia, Major  Depression Disorder, Seizures, Schizophrenia, Parkinsons, Traumatic Brain Injury,  Alzheimers, through novel therapeutic agents developed to modulate multiple  pathological signaling pathways involved in neurological and age related disorders.  Therapeutic products directed to reverse disease by targeting different pathways  recently identified in the pathogenesis of disease class.